Radioiodine in Low-Risk Thyroid Cancer | NEJM

Radioiodine is typically administered after thyroidectomy in patients with thyroid cancer, but its benefits in those with low-risk disease are controversial. New research findings are summarized in a short video.

To see the full article, follow this link: https://nej.md/3HvClQD

• #science_technology
• #nejm_group
• #nejm
• #the_new_england_journal_of_medicine
• #medical_research